genedrive (LON:GDR) Trading Down 4.4% – What’s Next?

genedrive plc (LON:GDR) shares were down 4.4% during trading on Tuesday . The stock traded as low as GBX 2.11 ($0.03) and last traded at GBX 2.15 ($0.03). Approximately 3,086,236 shares were traded during mid-day trading, an increase of 19% from the average daily volume of 2,585,487 shares. The stock had previously closed at GBX 2.25 ($0.03).

genedrive Stock Up 1.9 %

The company has a current ratio of 1.63, a quick ratio of 5.52 and a debt-to-equity ratio of 8.57. The firm’s fifty day moving average is GBX 2.25 and its 200 day moving average is GBX 2.50. The stock has a market cap of £11.62 million, a P/E ratio of -53.48 and a beta of -0.04.

Insider Buying and Selling

In other genedrive news, insider Ian David Gilham acquired 225,000 shares of genedrive stock in a transaction dated Friday, December 20th. The stock was bought at an average cost of GBX 2 ($0.02) per share, with a total value of £4,500 ($5,505.93). 14.75% of the stock is owned by insiders.

genedrive Company Profile

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.